Results 101 to 110 of about 3,227,713 (265)
Arthritis Care &Research, Volume 77, Issue 10, Page 1229-1239, October 2025.Objective The objective of this study was to determine a core set of measures for youth with juvenile spondyloarthritis and axial disease (axJSpA), using the juvenile arthritis working group Outcome Measures in Rheumatology framework. Methods This was a prospective multicenter study of youth with axJSpA.
Timothy G. Brandon +8 more
wiley +1 more source
Early IL‐1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes
ACR Open Rheumatology, Volume 7, Issue 10, October 2025.Objective Still's disease is a complex, multisystemic disorder requiring prompt diagnosis and treatment. This study provides a general assessment of a Still's disease cohort aiming to evaluate the efficacy of early intervention with interleukin‐1 inhibitors (IL‐1i) in achieving clinical inactive disease (CID) and reducing glucocorticoid use in patients
Sara Bindoli +5 more
wiley +1 more source
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth [PDF]
, 2014 Ningning Liu +22 more
openalex +1 more source
FRI0221 Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-tnf mode of action? [PDF]
, 2017 Axel Finckh +16 more
openalex +1 more source
From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index
Allergy, EarlyView.
Thomas Bieber +3 more
wiley +1 more source
Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study
British Journal of Clinical Pharmacology, Volume 91, Issue 10, Page 2979-2987, October 2025.Abstract Aims Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for
Ditte Resendal Gotfredsen +5 more
wiley +1 more source
British Journal of Clinical Pharmacology, Volume 91, Issue 10, Page 2998-3008, October 2025.Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys +5 more
wiley +1 more source
Hydroxychloroquine‐Induced Bradycardia in a Male Patient With Sarcoidosis: A Case Report
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Hydroxychloroquine (HCQ) is often used in sarcoidosis as a steroid‐sparing agent. Though generally safe, rare cardiac side effects like bradycardia can occur, especially in patients with underlying cardiac vulnerability. A 40‐year‐old South Asian male with biopsy‐proven sarcoidosis, stable on HCQ, azathioprine, and prednisolone, presented with
Sana Rasheed +4 more
wiley +1 more source
Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy
Diabetes/Metabolism Research and Reviews, Volume 41, Issue 7, October 2025.While disease‐modifying therapies (DMTs) have been used to treat autoimmune diseases for decades, until recently, DMTs had not been used to treat autoimmune type 1 diabetes (T1D). The approval of the first DMT for use in individuals with preclinical T1D, teplizumab, has ushered in a new era in which healthcare providers can slow the T1D disease course.
Aaron W. Michels +3 more
wiley +1 more source
Journal of Mass Spectrometry, Volume 60, Issue 10, October 2025.ABSTRACT Pitangueira (Eugenia uniflora) is a fruit tree found in the Cerrado, Caatinga, and Atlantic Forest Brazilian biomes. Due to its intense and characteristic aroma and flavor, its fruits (Brazilian cherry) can be consumed raw and as an ingredient in jellies, giving it better use and a more excellent shelf life.
Viviane D. M. Silva +10 more
wiley +1 more source